ArticleMikrochimica acta2019
Colorimetric and fluorometric aggregation-based heparin assay by using gold nanoclusters and gold nanoparticles.
Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 18 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
An optical nanoprobe consisting of gold nanoclusters (AuNCs) and gold nanoparticles (AuNPs) is described for ultrasensitive detection of heparin (Hep). Polyethyleneimine (PEI) induces the aggregation of AuNPs which results in a color change from wine red (peak at 520 nm) to blue (peak at 610 nm). In parallel, the fluorescence of AuNCs (with excitation/emission maxima at 370/610 nm) is weakened. However, in the presence of Hep (which is strongly negatively charged), it will electrostatically bind to positively charged PEI and then will prevent aggregation. Hence, the color changes from blue (aggregated) to red (non-aggregated). In parallel, fluorescence remains unchanged. Hep can be quantified by using the nanoprobe in the range of 4-220 ng·mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.